Obesity and sex hormones

Cancer Prevention and Management through Exercise and Weight Control

Volumn , Issue , 2016, Pages 289-300

  Kaaks, Rudolf ^a   McTiernan, Anne ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856910449     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention, Vol. 6, Weight Control and Physical Activity, Lyon, IARC Press, 2002.
2. Rajala, M. and Scherer, P. Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765, 2003.
3. Reaven, G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595, 1988.
4. Wajchenberg, B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21, 697, 2000.
5. Dickson, R.B. and Stancel, G.M. Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr, 27, 135-145, 2000.
6. Flototto, T. et al. Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer. Horm Metab Res 33, 451, 2001.
7. Key, T. and Pike, M. The dose-effect relationship between "unopposed" estrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer. Br J Cancer 57, 205, 1988.
8. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94, 606, 2002.
9. Zeleniuch-Jacquotte, A. et al. Postmenopausal levels of estrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 90, 153, 2004.
10. Key, T.J. et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95, 1218, 2003.
11. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350, 1047, 1997.
12. Schairer, C. et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 283, 485, 2000.
13. Huang, Z. et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 278, 1407, 1997.
14. Feigelson, H. et al. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 13, 220, 2004.
15. Morimoto, L. et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative. Cancer Causes Control. 13, 741, 2002.
16. MacInnis, R.J. et al. Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 13, 2117, 2004.
17. Coates, R. et al. Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst 82, 1684, 1990.
18. Tretli, S., Haldorsen, T. and Ottestad, L. The effect of premorbid height and weight on the survival of breast cancer patients. Br J Cancer 62, 299, 1990.
19. Maehle, B.O. and Tretli, S. Premorbid body mass index in breast cancer: reversed effect on survival in hormone receptor negative patients. Breast Cancer Res Treat 41, 123, 1996.
20. Reeves, M. et al. Body mass and breast cancer, relationship between method of detection and stage of disease. Cancer 77, 301, 1996.
21. Lukanova, A. et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108, 425, 2004.
22. Zeleniuch-Jacquotte, A. et al. Postmenopausal endogenous estrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer 84, 975, 2001.
23. Key, T. and Pike, M. The dose-effect relationship between "unopposed" estrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer. Br J Cancer 57, 205, 1988.
24. Kaaks, R., Lukanova, A., and Kurzer, M.S. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11, 1531, 2002.
25. Kaaks, R., Lukanova, A. and Sommersberg, B. Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis 3, 157, 2000.
26. Hsing, A.W., Reichardt, J.K. and Stanczyk, F.Z. Hormones and prostate cancer: current perspectives and future directions. Prostate 52, 213, 2002.
27. Bosland, M.C. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr, 39, 2000.
28. Gann, P.H. et al. Prospective study of sex hormone levels and risk of prostate cancer. J. Natl Cancer Inst 88, 1118, 1996.
29. Porter, M.P. and Stanford, J.L. Obesity and the risk of prostate cancer. Prostate 62, 316, 2004.
30. Howell, A., on behalf of the ATAC Trialists' Group A. The ATAC ("Arimidex," Tamoxifen, alone or in combination) trial in postmenopausal women with early breast cancer - updated efficacy results based on a median follow-up of 5 years. Breast Cancer Res Treat 88, 1S, 2004.
31. Chlebowski, R.T. et al. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition. J Clin Oncol 20, 3328, 2002.
32. Meldrum, D. et al. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 57, 624, 1981.
33. Siiteri, PK. Adipose tissue as a source of hormones. Am J Clin Nutr 45, 277, 1987.
34. Siiteri, PK. et al. The serum transport of steroid hormones. Recent Program Horm Res 38, 457, 1982.
35. Judd, H.L. et al. Origin of serum estradiol in postmenopausal women. Obstet Gynecol 59, 680, 1982.
36. Verkasalo, PK. et al. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 12, 47, 2001.
37. Boyapati, S.M. et al. Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in postmenopausal Chinese women. Cancer Causes Control 15, 305, 2004.
38. Lukanova, A. et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol. 150, 161, 2004.
39. Hankinson, S.E. et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 87, 1297, 1995.
40. Wu, A.H. et al. Soy intake and other lifestyle determinants of serum estrogen levels among postmenopausal Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 11, 844, 2002.
41. Goodman-Gruen, D. and Barrett-Connor, E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23, 912, 2000.
42. Madigan, M.P. et al. Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States). Cancer Causes Control. 9, 199, 1998.
43. Cauley, J.A. et al. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129, 1120, 1989.
44. Kaye, S.A. et al. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 20, 151, 1991.
45. Newcomb, P.A. et al. Association of dietary and life-style factors with sex hormones in postmenopausal women. Epidemiology 6, 318, 1995.
46. Potischman, N. et al. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88, 756, 1996.
47. Kirschner, M.A. et al. Androgen-estrogen metabolism in women with upper body vs. lower body metabolism. J Clin Endocrinol Metab 70, 473, 1990.
48. Haffner, S.M., Katz, M.S., and Dunn, J.F. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obesity 15, 417, 1991.
49. Pasqueli, R. et al. Determinants of sex hormone binding globulin concentrations in premenopausal and postmenopausal women with different estrogen status. Metabolism 46, 5, 1997
50. McTiernan, A. et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 21, 1961, 2003.
51. Shapira, D.V., Kumar, N.B., Lyman, G.H. Obesity, body fat distribution, and sex hormones in breast cancer patients. Cancer 67, 2215, 1991.
52. Wu, A.H., Pike, M.C., and Stram, D.O. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91, 529, 1999.
53. Crighton, I.L. et al. The effect of a low-fat diet on hormone levels in healthy pre- and postmenopausal women: relevance for breast cancer. Eur J Cancer 28A, 2024, 1992.
54. Prentice, R. et al. Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group. J Natl Cancer Inst 82, 129, 1990.
55. Heber, D., Ashley, J.M., Leaf, D.A., Barnard, R.J. Reduction of serum estradiol in postmenopausal women given free access to low-fat high-carbohydrate diet. Nutrition 7, 137, 1991.
56. Ingram, D.M. et al. Effect of low-fat diet on female sex hormone levels. J Natl Cancer Inst 79, 1225, 1987.
57. McTiernan, A. et al. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res. 64, 2923, 2004.
58. Vermeulen, A. et al. Estradiol in elderly men. Aging Male 5, 98, 2002.
59. Shono, N. et al. The relationships of testosterone, estradiol, dehydroepiandrosterone-sulfate and sex hormone-binding globulin to lipid and glucose metabolism in healthy men. J Atherosclerosis Thrombosis 3, 45, 1996.
60. Haffner, S.M. et al. Obesity, body fat distribution and sex hormones in men. Int J Obes Relat Metab Disord. 17, 643, 1993.
61. Ferrini, R.L. and Barrett-Connor, E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 147, 750, 1998.
62. Tchernof, A. and Despres, J.P Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res 32, 526, 2000.
63. Key, T.J. et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95, 1218, 2003.
64. Key, T.J. et al. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 60, 81, 2001.
65. Pugeat, M. et al. Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol 40, 841, 1991.
66. Kokkoris, P. and Pi-Sunyer, F.X. Obesity and endocrine disease. Endocrinol Metab Clin North Am 32, 895, 2003.
67. Kaaks, R., Lukanova, A., and Sommersberg, B. Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis 3, 157, 2000.
68. Ehrmann, D.A., Barnes, R.B., and Rosenfield, R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16, 322, 1995.
69. Dunaif, A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18, 774, 1997.
70. Robinson, S. et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf) 39, 351, 1993.
71. McTiernan, A. et al. Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev 13, 1099, 2004.
72. Svartberg, J. et al. Waist circumference and testosterone levels in community dwelling men. The Tromso study. Eur J Epidemiol 19,657, 2004.
73. Haffner, S.M. et al. Obesity, body fat distribution and sex hormones in men. Int J Obes Relat Metab Disord 17, 643, 1993.
74. Khaw, K.T. and Barrett-Connor, E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol 2, 675, 1992.
75. Field, A.E. et al. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 79, 1310, 1994.
76. Vermeulen, A., Kaufman, J.M., and Giagulli, V.A. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81, 1821, 1996.
77. Wu, A.H. et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 4, 735, 1995.
78. Pasquali, R. et al. Weight loss and sex steroid metabolism in massively obese man. J Endocrinol Invest 11, 205, 1988.
79. Pasquali, R. et al. Achievement of near-normal body weight as the prerequisite to normalize sex hormone-binding globulin concentrations in massively obese men. Int J Obesity Relat Metab Disord 21, 1, 1997.
80. Hankinson, S.E. et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91, 629, 1999.
81. Manjer, J. et al. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes Control. 14, 599, 2003.